Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hirsh

Showing results (1-10 of 666) with videos related to

Pageof 67
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1986
Effectiveness of anticoagulantsJ Hirsh
JAMA|June 8, 1984
New approaches for deep vein thrombosis occurring after surgeryJ Hirsh
Haemostasis|October 1, 1996
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosisJ Hirsh
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Low dose heparin prophylaxisJ Hirsh
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Decapitated Drosophila: a novel system for the study of biogenic aminesJ Hirsh
Seminars in Hematology|October 1, 1977
HypercoagulabilityJ Hirsh
The New England Journal of Medicine|June 22, 1995
The optimal duration of anticoagulant therapy for venous thrombosisJ Hirsh
Thrombosis and Haemostasis|July 1, 1993
Low molecular weight heparinJ Hirsh
Canadian Medical Association Journal|February 17, 1973
PlateletsJ Hirsh
American Heart Journal|April 1, 1992
Antithrombotic therapy in deep vein thrombosis and pulmonary embolismJ Hirsh
Pageof 67

Showing results (1-10 of 666) with videos related to

Sort By:
Pageof 67
Seminars in Thrombosis and Hemostasis|January 1, 1986
Effectiveness of anticoagulantsJ Hirsh
JAMA|June 8, 1984
New approaches for deep vein thrombosis occurring after surgeryJ Hirsh
Haemostasis|October 1, 1996
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosisJ Hirsh
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Low dose heparin prophylaxisJ Hirsh
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Decapitated Drosophila: a novel system for the study of biogenic aminesJ Hirsh
Seminars in Hematology|October 1, 1977
HypercoagulabilityJ Hirsh
The New England Journal of Medicine|June 22, 1995
The optimal duration of anticoagulant therapy for venous thrombosisJ Hirsh
Thrombosis and Haemostasis|July 1, 1993
Low molecular weight heparinJ Hirsh
Canadian Medical Association Journal|February 17, 1973
PlateletsJ Hirsh
American Heart Journal|April 1, 1992
Antithrombotic therapy in deep vein thrombosis and pulmonary embolismJ Hirsh
Pageof 67